2021 Q1 Form 10-Q Financial Statement

#000155837021006171 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $97.87M $116.6M
YoY Change -16.07% -6.01%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.800M $7.100M
YoY Change -4.23% 1.43%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $6.865M $13.77M
YoY Change -50.14% -6.04%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $63.87M $44.16M
YoY Change 44.65% -32.24%
Income Tax $13.10M $9.317M
% Of Pretax Income 20.51% 21.1%
Net Earnings $50.77M $34.84M
YoY Change 45.73% -32.88%
Net Earnings / Revenue 51.87% 29.88%
Basic Earnings Per Share $0.80 $0.54
Diluted Earnings Per Share $0.80 $0.53
COMMON SHARES
Basic Shares Outstanding 63.31M 65.07M
Diluted Shares Outstanding 63.42M 65.23M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.035B $3.958B
YoY Change 52.48%
Cash & Equivalents $1.968B $354.7M
Short-Term Investments $4.067B $3.603B
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $471.8M $494.7M
YoY Change -4.62% -2.04%
Goodwill $282.5M $282.5M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $14.92B $12.51B
YoY Change 19.31% 3.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $439.0M $266.0M
YoY Change 65.04% -4.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $439.0M $266.0M
YoY Change 65.04% -4.66%
LONG-TERM LIABILITIES
Long-Term Debt $135.0M $135.0M
YoY Change 0.0% -15.63%
Other Long-Term Liabilities $238.0M $224.0M
YoY Change 6.25% 13.71%
Total Long-Term Liabilities $373.0M $359.0M
YoY Change 3.9% 0.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $439.0M $266.0M
Total Long-Term Liabilities $373.0M $359.0M
Total Liabilities $12.73B $10.36B
YoY Change 22.82% 3.2%
SHAREHOLDERS EQUITY
Retained Earnings $2.306B $2.192B
YoY Change 5.18%
Common Stock $96.31M $96.23M
YoY Change 0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.193B $2.143B
YoY Change
Total Liabilities & Shareholders Equity $14.92B $12.51B
YoY Change 19.31% 3.98%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $50.77M $34.84M
YoY Change 45.73% -32.88%
Depreciation, Depletion And Amortization $6.800M $7.100M
YoY Change -4.23% 1.43%
Cash From Operating Activities $95.51M $56.62M
YoY Change 68.67% -16.36%
INVESTING ACTIVITIES
Capital Expenditures $1.614M $2.769M
YoY Change -41.71% -54.83%
Acquisitions
YoY Change
Other Investing Activities -$860.3M -$242.6M
YoY Change 254.62% 192.29%
Cash From Investing Activities $83.76M -$245.3M
YoY Change -134.14% 175.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $48.00K $29.37M
YoY Change -99.84% 54290.74%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 736.9M 286.6M
YoY Change 157.14% 432.71%
NET CHANGE
Cash From Operating Activities 95.51M 56.62M
Cash From Investing Activities 83.76M -245.3M
Cash From Financing Activities 736.9M 286.6M
Net Change In Cash 916.2M 97.89M
YoY Change 835.98% 202.43%
FREE CASH FLOW
Cash From Operating Activities $95.51M $56.62M
Capital Expenditures $1.614M $2.769M
Free Cash Flow $93.89M $53.85M
YoY Change 74.35% -12.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000315709
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
000-09439
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
INTERNATIONAL BANCSHARES CORPORATION
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2157138
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1200 San Bernardo Avenue
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Laredo
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78042-1359
CY2021Q1 dei City Area Code
CityAreaCode
956
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
722-7611
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $1.00 par value
CY2021Q1 dei Trading Symbol
TradingSymbol
IBOC
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63359714
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1967770000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1997238000
CY2021Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2021Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3400000
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3400000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4034746000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3054289000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4057357000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3080768000
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
6125000
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
6202000
CY2021Q1 us-gaap Marketable Securities
MarketableSecurities
4066882000
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
3090370000
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7462358000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7541754000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
108408000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
109059000
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
7353950000
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
7432695000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
471823000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
479878000
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
31790000
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
37881000
CY2021Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
285511000
CY2020Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
254413000
CY2021Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
292143000
CY2020Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
292381000
CY2021Q1 us-gaap Goodwill
Goodwill
282532000
CY2020Q4 us-gaap Goodwill
Goodwill
282532000
CY2021Q1 us-gaap Other Assets
OtherAssets
169132000
CY2020Q4 us-gaap Other Assets
OtherAssets
162079000
CY2021Q1 us-gaap Assets
Assets
14921533000
CY2020Q4 us-gaap Assets
Assets
14029467000
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
5221897000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
4715814000
CY2021Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
4114937000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
3852505000
CY2021Q1 us-gaap Time Deposits
TimeDeposits
2144146000
CY2020Q4 us-gaap Time Deposits
TimeDeposits
2153541000
CY2021Q1 us-gaap Deposits
Deposits
11480980000
CY2020Q4 us-gaap Deposits
Deposits
10721860000
CY2021Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
439333000
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
428148000
CY2021Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
436280000
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
436327000
CY2021Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2020Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2021Q1 us-gaap Other Liabilities
OtherLiabilities
237693000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
130492000
CY2021Q1 us-gaap Liabilities
Liabilities
12728928000
CY2020Q4 us-gaap Liabilities
Liabilities
11851469000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96312390
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96240977
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
96312000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
96241000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150972000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
149334000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2305584000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2289626000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17813000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20825000
CY2021Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2570681000
CY2020Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2556026000
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
32962288
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
32961289
CY2021Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
378076000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
378028000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2192605000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2177998000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14921533000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14029467000
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
92114000
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
99230000
CY2021Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
4875000
CY2020Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
16488000
CY2021Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
395000
CY2020Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
766000
CY2021Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
490000
CY2020Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
128000
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
97874000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
116612000
CY2021Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
929000
CY2020Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
3235000
CY2021Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
3198000
CY2020Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
5970000
CY2021Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
141000
CY2021Q1 us-gaap Interest Expense Other Domestic Deposits
InterestExpenseOtherDomesticDeposits
1889000
CY2020Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
465000
CY2020Q1 us-gaap Interest Expense Other Domestic Deposits
InterestExpenseOtherDomesticDeposits
2826000
CY2020Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
7109000
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
5617000
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
6899000
CY2021Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
6799000
CY2021Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
708000
CY2020Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
1273000
CY2021Q1 us-gaap Interest Expense
InterestExpense
6865000
CY2020Q1 us-gaap Interest Expense
InterestExpense
13769000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
91009000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
102843000
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1192000
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
16836000
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
89817000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
86007000
CY2021Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-4000
CY2020Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-5000
CY2021Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
4085000
CY2020Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
-231000
CY2021Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
3630000
CY2020Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
4809000
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
36237000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
35130000
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30162000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
36330000
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
2836000
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
3970000
CY2021Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
887000
CY2021Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
-1245000
CY2020Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
-3002000
CY2021Q1 us-gaap Advertising Expense
AdvertisingExpense
1423000
CY2020Q1 us-gaap Advertising Expense
AdvertisingExpense
1984000
CY2021Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4440000
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4491000
CY2021Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
8776000
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
13197000
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
62185000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
76982000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
63869000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
44155000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13098000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9317000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
50771000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
34838000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63307455
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65070589
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63419706
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
50771000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65228824
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
34838000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-801000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
16482000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3015000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
62003000
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
1000
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
1000
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-3000
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-4000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3012000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
62007000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47759000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
96845000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2177998000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
50771000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.55
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
34813000
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
999
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
48000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1550000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
159000
CY2021Q1 iboc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Net Of Reclassification Adjustment
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringNetOfReclassificationAdjustment
-3012000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2192605000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2118053000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
34838000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.55
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
35128000
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1200614
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
29371000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
225000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
219000
CY2020Q1 iboc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Net Of Reclassification Adjustment
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringNetOfReclassificationAdjustment
62007000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2142511000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
50771000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
34838000
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1192000
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
16836000
CY2021Q1 us-gaap Other Real Estate Covered Valuation Adjustments
OtherRealEstateCoveredValuationAdjustments
-150000
CY2020Q1 us-gaap Other Real Estate Covered Valuation Adjustments
OtherRealEstateCoveredValuationAdjustments
-537000
CY2021Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
6799000
CY2020Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
7109000
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
34000
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
358000
CY2021Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
219000
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
79000
CY2021Q1 iboc Accretion Of Discounts Investments
AccretionOfDiscountsInvestments
138000
CY2020Q1 iboc Accretion Of Discounts Investments
AccretionOfDiscountsInvestments
120000
CY2021Q1 iboc Amortization Of Investment Securities Premiums
AmortizationOfInvestmentSecuritiesPremiums
11576000
CY2020Q1 iboc Amortization Of Investment Securities Premiums
AmortizationOfInvestmentSecuritiesPremiums
7373000
CY2021Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-4000
CY2020Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-5000
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-77000
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
30000
CY2021Q1 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
2870000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
159000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
219000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2448000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-521000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-64000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14123000
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-6091000
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
450000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9931000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
228000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
8788000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4571000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
95505000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56621000
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Other Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
556199000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Other Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
1075000
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2510000
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
18920000
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2017685000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
421017000
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS
568011000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS
257223000
CY2021Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-60966000
CY2020Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
120789000
CY2021Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
34086000
CY2020Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
6760000
CY2021Q1 iboc Distributions From Other Investments
DistributionsFromOtherInvestments
2201000
CY2020Q1 iboc Distributions From Other Investments
DistributionsFromOtherInvestments
26382000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1614000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2769000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
34000
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
370000
CY2021Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
1544000
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
2034000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-861920000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-245331000
CY2021Q1 iboc Increase Decrease In Noninterest Bearing Demand Deposits
IncreaseDecreaseInNoninterestBearingDemandDeposits
506083000
CY2020Q1 iboc Increase Decrease In Noninterest Bearing Demand Deposits
IncreaseDecreaseInNoninterestBearingDemandDeposits
118934000
CY2021Q1 iboc Increase Decrease In Saving And Interest Bearing Demand Deposits
IncreaseDecreaseInSavingAndInterestBearingDemandDeposits
262432000
CY2020Q1 iboc Increase Decrease In Saving And Interest Bearing Demand Deposits
IncreaseDecreaseInSavingAndInterestBearingDemandDeposits
22127000
CY2021Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-9395000
CY2020Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
42793000
CY2021Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
11185000
CY2020Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
29936000
CY2021Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
-47000
CY2020Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
101954000
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29371000
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1550000
CY2020Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
225000
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
34813000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
736947000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
286598000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29468000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
97888000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1997238000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
256820000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1967770000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
354708000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
7984000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
13353000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
206000
CY2021Q1 iboc Investment Securities Purchases Not Yet Settled
InvestmentSecuritiesPurchasesNotYetSettled
100933000
CY2021Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
16587000
CY2020Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
486000
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
35128000
CY2020Q1 iboc Transfer From Bank Premise And Equipment To Other Assets
TransferFromBankPremiseAndEquipmentToOtherAssets
7546000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q1 iboc Number Of Active Operating Subsidiaries
NumberOfActiveOperatingSubsidiaries
5
CY2021Q1 iboc Impaired Financing Receivable Recorded Investment Fair Value Disclosure
ImpairedFinancingReceivableRecordedInvestmentFairValueDisclosure
1869000
CY2021Q1 iboc Impaired Commercial Collateral Financing Receivable Appraisals To Determine Fair Value
ImpairedCommercialCollateralFinancingReceivableAppraisalsToDetermineFairValue
468000
CY2021Q1 iboc Impaired Collateral Dependent Commercial Loans With Internal Evaluation Completed Within Last Twelve Months
ImpairedCollateralDependentCommercialLoansWithInternalEvaluationCompletedWithinLastTwelveMonths
1207000
CY2020Q4 iboc Impaired Financing Receivable Recorded Investment Fair Value Disclosure
ImpairedFinancingReceivableRecordedInvestmentFairValueDisclosure
18361000
CY2020Q4 iboc Impaired Commercial Collateral Financing Receivable Appraisals To Determine Fair Value
ImpairedCommercialCollateralFinancingReceivableAppraisalsToDetermineFairValue
16587000
CY2020Q4 iboc Impaired Collateral Dependent Commercial Loans With Internal Evaluation Completed Within Last Twelve Months
ImpairedCollateralDependentCommercialLoansWithInternalEvaluationCompletedWithinLastTwelveMonths
1283000
CY2021Q1 iboc Allowance For Loan And Lease Losses Period Increase Decrease Loans Transferred To Other Real Estate Owned
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecreaseLoansTransferredToOtherRealEstateOwned
0
CY2020 iboc Allowance For Loan And Lease Losses Period Increase Decrease Loans Transferred To Other Real Estate Owned
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecreaseLoansTransferredToOtherRealEstateOwned
22000
CY2021Q1 iboc Allowance For Loan Lease Losses Write Offs Prior To Foreclosure
AllowanceForLoanLeaseLossesWriteOffsPriorToForeclosure
150000
CY2020 iboc Allowance For Loan Lease Losses Write Offs Prior To Foreclosure
AllowanceForLoanLeaseLossesWriteOffsPriorToForeclosure
1539000
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7462358000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7541754000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
109059000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2353000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
510000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
1843000
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1192000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
108408000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
60278000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2980000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
792000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
2188000
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
16836000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
85273000
CY2021Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
2681000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
279000
CY2021Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
7459677000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
108129000
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
19447000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
279000
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
7522307000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
108780000
CY2021Q1 us-gaap Financing Receivable Threshold Period Past Due Writeoff
FinancingReceivableThresholdPeriodPastDueWriteoff
P90D
CY2021Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
9105000
CY2021Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2895000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
19822000
CY2021Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
8913000
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
5821000
CY2021Q2 iboc Financing Receivable With Payment Deferrals
FinancingReceivableWithPaymentDeferrals
602000000
CY2021Q2 iboc Financing Receivable With Payment Deferrals
FinancingReceivableWithPaymentDeferrals
602000000
CY2021Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
33372000
CY2021Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
7428986000
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7462358000
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
8238000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
38258000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
7503496000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7541754000
CY2021Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
836952000
CY2021Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
3010552000
CY2021Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
1533431000
CY2021Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
999919000
CY2021Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
495275000
CY2021Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
586229000
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7462358000
CY2020Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
3601680000
CY2020Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
1627511000
CY2020Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
1087031000
CY2020Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
556923000
CY2020Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
327336000
CY2020Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
341273000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7541754000
CY2021Q1 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
3400000
CY2021Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2021Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3400000
CY2021Q1 iboc Equity Securities And Available For Sale Debt Securities Amortized Cost Basis
EquitySecuritiesAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
4034746000
CY2021Q1 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Gains
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedGains
31741000
CY2021Q1 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Losses
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedLosses
9130000
CY2020Q4 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
3400000
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3400000
CY2020Q4 iboc Equity Securities And Available For Sale Debt Securities Amortized Cost Basis
EquitySecuritiesAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
3054289000
CY2020Q4 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Gains
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedGains
35832000
CY2020Q4 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Losses
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedLosses
9353000
CY2021Q1 us-gaap Heldtomaturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost
HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost
1075000
CY2021Q1 us-gaap Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value
HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
1075000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
945682000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
945682000
CY2021Q1 us-gaap Heldtomaturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost
HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost
2325000
CY2021Q1 us-gaap Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value
HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
2325000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
355000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
356000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis
44756000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
48283000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
3043953000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
3063036000
CY2021Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3400000
CY2021Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4034746000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4057357000
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2510000
CY2021Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
0
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-4
CY2021Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-77000
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-77000
CY2020Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
30000
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
18920000
CY2020Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
0
CY2020Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2020Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-5
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1518962000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
9120000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
536000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
10000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1519498000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9130000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1462232000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
9339000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
757000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
14000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1462989000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9353000
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
6125000
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
6202000
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
30000
CY2021Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
436280000
CY2021Q1 iboc Percentage Of Advances From Federal Home Loan Banks Increase Decrease
PercentageOfAdvancesFromFederalHomeLoanBanksIncreaseDecrease
0
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
436327000
CY2021Q1 iboc Number Of Statutory Business Trusts Issuing Preferred Securities
NumberOfStatutoryBusinessTrustsIssuingPreferredSecurities
5
CY2021Q1 iboc Number Of Statutory Business Trusts Issuing Preferred Securities
NumberOfStatutoryBusinessTrustsIssuingPreferredSecurities
5
CY2021Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2020Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2021Q1 iboc Maximum Number Of Consecutive Quarterly Periods Available For Deferral Of Payment Of Interest
MaximumNumberOfConsecutiveQuarterlyPeriodsAvailableForDeferralOfPaymentOfInterest
20
CY2021Q1 iboc Maximum Percentage Of Capital Securities Issued By Trust Qualifying As Tier One Capital
MaximumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
0.25
CY2021Q1 iboc Minimum Percentage Of Capital Securities Issued By Trust Qualifying As Tier Two Capital
MinimumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierTwoCapital
0.25
CY2021Q1 iboc Capital Securities Issued By Trust Qualifying As Tier One Capital
CapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
134642000
CY2020Q4 iboc Capital Securities Issued By Trust Qualifying As Tier One Capital
CapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
134642000
CY2021Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.55
CY2009Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
40000000
CY2009Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P12M
CY2021Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000
CY2021Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P12M
CY2021Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
12268401
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
357102000
CY2021Q1 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
19.27
CY2020Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
19.05
CY2021Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
14.52
CY2020Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
14.92
CY2021Q1 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
20.44
CY2020Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
20.25
CY2021Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
21.58
CY2020Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
21.40
CY2021Q1 iboc Maximum Percentage Of Capital Securities Issued By Trust Qualifying As Tier One Capital
MaximumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
0.25
CY2021Q1 iboc Minimum Percentage Of Capital Securities Issued By Trust Qualifying As Tier Two Capital
MinimumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierTwoCapital
0.25
CY2021Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000

Files In Submission

Name View Source Status
0001558370-21-006171-index-headers.html Edgar Link pending
0001558370-21-006171-index.html Edgar Link pending
0001558370-21-006171.txt Edgar Link pending
0001558370-21-006171-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iboc-20210331.xsd Edgar Link pending
iboc-20210331x10q.htm Edgar Link pending
iboc-20210331x10q_htm.xml Edgar Link completed
iboc-20210331xex31da.htm Edgar Link pending
iboc-20210331xex31db.htm Edgar Link pending
iboc-20210331xex32da.htm Edgar Link pending
iboc-20210331xex32db.htm Edgar Link pending
iboc-20210331_cal.xml Edgar Link unprocessable
iboc-20210331_def.xml Edgar Link unprocessable
iboc-20210331_lab.xml Edgar Link unprocessable
iboc-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending